{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T10:06:09Z","timestamp":1749549969012,"version":"3.40.5"},"reference-count":116,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NRF of South Africa","award":["FA2006031300003"],"award-info":[{"award-number":["FA2006031300003"]}]},{"name":"Centre of Excellence for Pharmaceutical Sciences"},{"name":"Pharmaceutical Society of South Africa"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.ejps.2017.10.033","type":"journal-article","created":{"date-parts":[[2017,11,5]],"date-time":"2017-11-05T23:13:44Z","timestamp":1509923624000},"page":"503-513","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Formulation and evaluation of selected transmucosal dosage forms containing a double fixed-dose of acyclovir and ketoconazole"],"prefix":"10.1016","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2489-1616","authenticated-orcid":false,"given":"Joe M.","family":"Viljoen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan\u00e9lia","family":"Botes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan H.","family":"Steenekamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2017.10.033_bb0005","series-title":"Goodman & Gillman's: the pharmacological basis of therapeutics","first-page":"1 594","article-title":"Antiviral agents: (Nonretroviral)","author":"Acosta","year":"2011"},{"key":"10.1016\/j.ejps.2017.10.033_bb0010","first-page":"1","article-title":"CD4 count pattern and demographic distribution of treatment-Na\u00efve HIV patients in Lagos, Nigeria","volume":"1012","author":"Akinbami","year":"2012","journal-title":"AIDS Res. Treat."},{"issue":"3","key":"10.1016\/j.ejps.2017.10.033_bb0015","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s11908-015-0464-y","article-title":"Cutaneous manifestations of human immunodeficiency virus: a clinical update","volume":"17","author":"Altman","year":"2015","journal-title":"Curr. Infect. Dis. Rep."},{"year":"1996","series-title":"Culminal Methylcellulose, Methylydroxyethylcellulose, Methylhdroxypropylcellulose: Physical and Chemical Properties","author":"Aqualon","key":"10.1016\/j.ejps.2017.10.033_bb0020"},{"issue":"6","key":"10.1016\/j.ejps.2017.10.033_bb0025","doi-asserted-by":"crossref","first-page":"2 069","DOI":"10.1021\/la035031x","article-title":"Evaporation rates of water from concentrated oil-in-water emulsions","volume":"20","author":"Aranberri","year":"2004","journal-title":"Langmuir"},{"key":"10.1016\/j.ejps.2017.10.033_bb0030","series-title":"Pharmaceutics: the design and manufacture of medicines","first-page":"839","article-title":"Product stability and stability testing","author":"Aulton","year":"2013"},{"key":"10.1016\/j.ejps.2017.10.033_bb0035","first-page":"487","article-title":"Skin penetration","volume":"20","author":"Barret","year":"1969","journal-title":"J. Soc. Cosmet. Chem."},{"key":"10.1016\/j.ejps.2017.10.033_bb0040","series-title":"Pharmaceutics: the design and manufacture of medicines","first-page":"565","article-title":"Transdermal Drug Delivery","author":"Barry","year":"2007"},{"key":"10.1016\/j.ejps.2017.10.033_bb0045","doi-asserted-by":"crossref","first-page":"1 173","DOI":"10.1007\/s00396-008-1882-2","article-title":"Rheological properties of carboxymethyl cellulose (CMC) solutions","volume":"286","author":"Benchabane","year":"2008","journal-title":"Colloid Polym. Sci."},{"key":"10.1016\/j.ejps.2017.10.033_bb0050","series-title":"Goodman & Gillman's: the pharmacological basis of therapeutics","first-page":"1 571","article-title":"Antimicrobial agents: antifungal agents","author":"Bennett","year":"2011"},{"year":"2010","series-title":"AHFS Drug Information","author":"Bethesda","key":"10.1016\/j.ejps.2017.10.033_bb0055"},{"issue":"3","key":"10.1016\/j.ejps.2017.10.033_bb0060","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1016\/S0190-9622(08)81276-5","article-title":"Antifungal therapy: potential interactions with other classes of drugs","volume":"31","author":"Bickers","year":"1994","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ejps.2017.10.033_bb9000","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0378-5173(88)90235-9","article-title":"Physicochemical aspects of drug release. VIII. The relation between particle size and surface specific dissolution rate in agitated suspensions","volume":"47","author":"Bisrat","year":"1988","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.ejps.2017.10.033_bb0065","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/1721727X0600400205","article-title":"Effect of ultrasound on transdermal permeation of diclofenac","volume":"4","author":"van der Bijl","year":"2006","journal-title":"Eur. J. Inflamm."},{"key":"10.1016\/j.ejps.2017.10.033_bb0070","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.addr.2007.05.011","article-title":"Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates","volume":"59","author":"Blagden","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"author":"Blistex","key":"10.1016\/j.ejps.2017.10.033_bb0075"},{"issue":"1","key":"10.1016\/j.ejps.2017.10.033_bb0080","first-page":"5","article-title":"Synthesis and characterization of carboxymethyl cellulose from palm kernel cake","volume":"3","author":"Bono","year":"2009","journal-title":"Adv. Nat. Appl. Sci."},{"author":"British Pharmacopoeia (BP)","key":"10.1016\/j.ejps.2017.10.033_bb0085"},{"key":"10.1016\/j.ejps.2017.10.033_bb0090","doi-asserted-by":"crossref","first-page":"4 079","DOI":"10.1002\/jps.23721","article-title":"Preparation and physicochemical characterization of acyclovir cocrystals with improved dissolution properties","volume":"102","author":"Bruni","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2017.10.033_bb0095","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1758-2652-14-5","article-title":"New insights into HIV-1-primary skin disorders","volume":"14","author":"Cedeno-Laurent","year":"2011","journal-title":"J. Int. AIDS Soc."},{"author":"Centers for Disease Control (CDC)","key":"10.1016\/j.ejps.2017.10.033_bb0100"},{"key":"10.1016\/j.ejps.2017.10.033_bb0105","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jpba.2004.06.003","article-title":"Microcalorimetric evaluation of the in vitro compatibility of amoxicillin\/clavulanic acid and ampicillin\/sulbactam with ciprofloxacin","volume":"36","author":"Chadha","year":"2004","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejps.2017.10.033_bb0110","series-title":"Current Microscopy Contributions to Advances in Science and Technology","first-page":"1013","article-title":"Thermomicroscopy and its pharmaceuticals applications","volume":"2012","author":"Chadha","year":"2012"},{"author":"Clinicians Society (CS)","key":"10.1016\/j.ejps.2017.10.033_bb0115"},{"key":"10.1016\/j.ejps.2017.10.033_bb0120","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1023\/A:1016010207729","article-title":"Effect of change in shape factor of a single crystal on its dissolution behavior","volume":"1","author":"Dali","year":"1996","journal-title":"Pharm. Res."},{"issue":"3","key":"10.1016\/j.ejps.2017.10.033_bb0125","first-page":"217","article-title":"Kinetic modelling on drug release from controlled drug delivery systems","volume":"67","author":"Dash","year":"2010","journal-title":"Acta Pol. Pharm."},{"key":"10.1016\/j.ejps.2017.10.033_bb0130","doi-asserted-by":"crossref","first-page":"1 785","DOI":"10.1016\/S0002-9378(03)00873-1","article-title":"Penetration of toxic shock syndrome toxin-1 across porcine vaginal mucosa ex vivo: permeability characteristics, toxin distribution, and tissue damage","volume":"189","author":"Davis","year":"2003","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ejps.2017.10.033_bb0135","first-page":"12","article-title":"Cutaneous manifestations of HIV\/AIDS: part 1","volume":"5","author":"Dlova","year":"2004","journal-title":"South. Afr. J. HIV Med."},{"key":"10.1016\/j.ejps.2017.10.033_bb0140","first-page":"12","article-title":"Utaneous manifestations of HIV\/AIDS: part 2","volume":"6","author":"Dlova","year":"2005","journal-title":"South. Afr. J. HIV Med."},{"issue":"1","key":"10.1016\/j.ejps.2017.10.033_bb0145","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/0897190005284095","article-title":"Fungal opportunistic infections in HIV disease","volume":"19","author":"Duffalo","year":"2006","journal-title":"J. Pharm. Pract."},{"issue":"3","key":"10.1016\/j.ejps.2017.10.033_bb0150","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S1085-5629(97)80043-0","article-title":"Fungal infections in HIV-infected patients","volume":"16","author":"Durden","year":"1997","journal-title":"Semin. Cutan. Med. Surg."},{"key":"10.1016\/j.ejps.2017.10.033_bb0155","series-title":"Topical Applications and the Mucosa","first-page":"1","article-title":"Anatomical and physiological basis of topical therapy of the mucosa","author":"Elsner","year":"2011"},{"key":"10.1016\/j.ejps.2017.10.033_bb0160","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.archoralbio.2003.12.002","article-title":"Comparative permeability of various chemical markers through human vaginal and buccal mucosa as well as porcine buccal and mouth floor mucosa","volume":"49","author":"van Eyk","year":"2004","journal-title":"Arch. Oral Biol."},{"key":"10.1016\/j.ejps.2017.10.033_bb0165","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ijpharm.2005.09.002","article-title":"Porcine vaginal mucosa as an in vitro permeability model for human vaginal mucosa","volume":"305","author":"van Eyk","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2017.10.033_bb0170","series-title":"Topical Applications and the Mucosa","first-page":"116","article-title":"Assessing the dermal safety of products intended for genital mucosal exposure","author":"Farage","year":"2011"},{"key":"10.1016\/j.ejps.2017.10.033_bb0175","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1590\/S1984-82502013000200011","article-title":"Stability evaluation of organic lip balm","volume":"49","author":"Fernandes","year":"2013","journal-title":"Braz. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2017.10.033_bb0180","doi-asserted-by":"crossref","first-page":"602783","DOI":"10.1155\/2010\/602783","article-title":"Acyclovir nephrotoxicity: a case report highlighting the importance of prevention, detection, and treatment of acyclovir-induced nephropathy","volume":"2010","author":"Fleischer","year":"2010","journal-title":"Case Rep. Med."},{"key":"10.1016\/j.ejps.2017.10.033_bb0185","series-title":"Modern Pharmaceutics","first-page":"187","article-title":"Cutaneous and transdermal delivery \u2013 processes and systems of delivery","author":"Flynn","year":"2002"},{"key":"10.1016\/j.ejps.2017.10.033_bb0190","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.ijbiomac.2014.04.019","article-title":"In-vitro release of acyclovir loaded Eudragit RLPO\u00ae nanoparticles for sustained drug delivery","volume":"67","author":"Gandhi","year":"2014","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejps.2017.10.033_bb0195","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/(SICI)1097-4628(19970411)64:2<289::AID-APP9>3.0.CO;2-N","article-title":"Rheological properties of carboxymethyl cellulose","volume":"64","author":"Ghannam","year":"1997","journal-title":"J. Appl. Polym. Sci."},{"issue":"2","key":"10.1016\/j.ejps.2017.10.033_bb0200","first-page":"138","article-title":"Enhancement of transdermal penetration and bioavailability of poorly soluble acyclovir using solid lipid nanoparticles incorporated in gel cream","volume":"75","author":"Gide","year":"2013","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2017.10.033_bb0205","doi-asserted-by":"crossref","first-page":"1 180","DOI":"10.1111\/j.1365-2133.2009.09209.x","article-title":"Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1970 patients","volume":"161","author":"Gollnick","year":"2009","journal-title":"Br. J. Dermatol."},{"issue":"1","key":"10.1016\/j.ejps.2017.10.033_bb0210","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2174\/1567201052772906","article-title":"Mathematical modelling and controlled drug delivery: matrix systems","volume":"2","author":"Grassi","year":"2005","journal-title":"Curr. Drug Deliv."},{"issue":"1","key":"10.1016\/j.ejps.2017.10.033_bb0215","doi-asserted-by":"crossref","first-page":"65","DOI":"10.4103\/0253-7184.93836","article-title":"Skin diseases in HIV-infected patients: impact of immune status and histological correlation","volume":"33","author":"Halder","year":"2012","journal-title":"Indian J. Sex. Transm. Dis."},{"issue":"3","key":"10.1016\/j.ejps.2017.10.033_bb0220","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1468-3083.2011.04429.x","article-title":"Mucocutaneous manifestations of HIV-infected patients in the era of HAART in Guangxi Zhuang autonomous region, China","volume":"27","author":"Han","year":"2013","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"1\u20132","key":"10.1016\/j.ejps.2017.10.033_bb0225","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ijpharm.2007.11.009","article-title":"The development of microthermalanalysis and photothermalmicrospectroscopy as well as novel approaches to drug-excipient compatibility studies","volume":"354","author":"Harding","year":"2008","journal-title":"Int. J. Pharm."},{"issue":"9","key":"10.1016\/j.ejps.2017.10.033_bb0230","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/jps.3030490910","article-title":"Theoretical analysis of diffusional movement through heterogeneous barriers","volume":"49","author":"Higuchi","year":"1960","journal-title":"J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.ejps.2017.10.033_bb0235","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jconrel.2004.11.034","article-title":"The vagina as a route for systemic drug delivery","volume":"103","author":"Hussain","year":"2004","journal-title":"J. Control. Release"},{"issue":"1\u20132","key":"10.1016\/j.ejps.2017.10.033_bb0240","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ijpharm.2012.06.023","article-title":"A comparison of the physicochemical properties and a sensory test of acyclovir creams","volume":"436","author":"Inoue","year":"2012","journal-title":"Int. J. Pharm."},{"author":"International Conference on Harmonisation of Technical requirements for registration of pharmaceuticals for human use (ICH): QlA (R2)","key":"10.1016\/j.ejps.2017.10.033_bb0245"},{"issue":"2","key":"10.1016\/j.ejps.2017.10.033_bb0250","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3109\/10717544.2014.933283","article-title":"Topical delivery of acyclovir and ketoconazole","volume":"23","author":"Jacobs","year":"2016","journal-title":"Drug Deliv."},{"issue":"3","key":"10.1016\/j.ejps.2017.10.033_bb0255","first-page":"1 237","article-title":"Development of pH-sensitive insulin nanoparticles using Eudragit L100-55 and chitosan with different molecular weights","volume":"11","author":"Jelvehgari","year":"2010","journal-title":"Am. Assoc. Pharm. Scient."},{"key":"10.1016\/j.ejps.2017.10.033_bb0260","series-title":"Pharmaceutical Statistics Using SAS: A Practical Guide","first-page":"117","article-title":"Nonparametric methods in pharmaceutical statistics","author":"Juneau","year":"2007"},{"key":"10.1016\/j.ejps.2017.10.033_bb0265","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.addr.2015.04.017","article-title":"Vaginal drug distribution modelling","volume":"92","author":"Katz","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2017.10.033_bb0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/2373424","article-title":"Spectrum of opportunistic fungal infections in HIV\/AIDS patients in tertiary care hospital in India","volume":"2016","author":"Kaur","year":"2016","journal-title":"Can. J. Infect. Dis. Med. Microbiol."},{"key":"10.1016\/j.ejps.2017.10.033_bb0275","first-page":"1 790","article-title":"Rheological and electrokinetic properties of carboxymethylcellulose-water dispersions in the presence of salts","volume":"7","author":"Khaled","year":"2012","journal-title":"Int. J. Phys. Sci."},{"author":"Kim","key":"10.1016\/j.ejps.2017.10.033_bb0280"},{"key":"10.1016\/j.ejps.2017.10.033_bb0285","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0190-9622(88)70022-5","article-title":"History, pharmacokinetics and pharmacology of acyclovir","volume":"17","author":"King","year":"1988","journal-title":"J. Am. Acad. Dermatol."},{"issue":"9","key":"10.1016\/j.ejps.2017.10.033_bb0290","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1046\/j.1365-2133.2003.05741.x","article-title":"Functional properties of the surface of the vermilion border of the lips are distinct from those of the facial skin","volume":"150","author":"Kobayashi","year":"2004","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ejps.2017.10.033_bb0295","first-page":"851","article-title":"Permeability and barrier function of three porcine non-keratinized mucosae","volume":"80","author":"Kremer","year":"2001","journal-title":"J. Dent. Res."},{"issue":"1\u20132","key":"10.1016\/j.ejps.2017.10.033_bb0300","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ijpharm.2014.07.034","article-title":"Development of performance matrix for generic product equivalence of acyclovir topical creams","volume":"475","author":"Krishnaiah","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2017.10.033_bb0305","doi-asserted-by":"crossref","first-page":"2 723","DOI":"10.1016\/0032-3861(96)87634-8","article-title":"Characterization of aqueous carboxymethylcellulose solutions in term s of their molecular structure and its influence on rheological behaviour","volume":"37","author":"Kulicke","year":"1996","journal-title":"Polymer"},{"key":"10.1016\/j.ejps.2017.10.033_bb0310","series-title":"How to Report Statistics in Medicine: Annotated Guidelines for Authors, Editors and Reviewers","first-page":"1","author":"Lang","year":"1997"},{"author":"Langer","key":"10.1016\/j.ejps.2017.10.033_bb0315"},{"issue":"3","key":"10.1016\/j.ejps.2017.10.033_bb0320","first-page":"1 002","article-title":"Correlation between rheological properties, in vitro release, and percutaneous permeation of tetrahydropalmatine","volume":"12","author":"Li","year":"2011","journal-title":"Am. Assoc. Pharm. Scient."},{"key":"10.1016\/j.ejps.2017.10.033_bb0325","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ajps.2014.12.006","article-title":"Overview of milling techniques for improving the solubility of poorly water-soluble drugs","volume":"10","author":"Loh","year":"2015","journal-title":"Asian J. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.ejps.2017.10.033_bb0330","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.crad.2005.02.010","article-title":"MRI of the vaginal conditions","volume":"60","author":"Lopez","year":"2005","journal-title":"Clin. Radiol."},{"key":"10.1016\/j.ejps.2017.10.033_bb0335","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13567-015-0241-9","article-title":"A review of the human vs. porcine female genital tract and associated immune system in the perspective of using minipigs as a model of human genital chlamydia infection","volume":"46","author":"Lorenzen","year":"2015","journal-title":"Vet. Res."},{"issue":"3","key":"10.1016\/j.ejps.2017.10.033_bb0340","first-page":"83","article-title":"Labial mucosa as a novel transmucosal drug delivery platform","volume":"4","author":"Madhav","year":"2012","journal-title":"Int J Pharm Pharm Sci"},{"issue":"4","key":"10.1016\/j.ejps.2017.10.033_bb0345","first-page":"1 060","article-title":"Lip: an impressive and idealistic platform for drug delivery","volume":"4","author":"Madhav","year":"2011","journal-title":"J. Pharm. Res."},{"issue":"7","key":"10.1016\/j.ejps.2017.10.033_bb0350","first-page":"3 166","article-title":"Design and evaluation of novel rosiglitazone loaded bio lip-strips using novel biomaterial for systemic delivery through a novelistic translabial route","volume":"3","author":"Madhav","year":"2014","journal-title":"Int. J. Bioassays"},{"issue":"1","key":"10.1016\/j.ejps.2017.10.033_bb0355","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jconrel.2009.07.016","article-title":"Orotransmucosal drug delivery systems: a review","volume":"140","author":"Madhav","year":"2009","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.ejps.2017.10.033_bb0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1470-9465.2004.00841.x","article-title":"History of the development of azole derivates","volume":"10","author":"Maertens","year":"2004","journal-title":"Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.ejps.2017.10.033_bb0365","series-title":"Pharmaceutics: The Design and Manufacture of Medicines","first-page":"94","article-title":"Rheology","author":"Marriott","year":"2013"},{"year":"2011","series-title":"Stability: Registration of Medicine","author":"Medicines Control Council (MCC)","key":"10.1016\/j.ejps.2017.10.033_bb0370"},{"year":"1997","series-title":"New Cosmetic Science","author":"Mitsui","key":"10.1016\/j.ejps.2017.10.033_bb0375"},{"issue":"10","key":"10.1016\/j.ejps.2017.10.033_bb0380","first-page":"1","article-title":"Illness appraisals and depression in the first year after HIV diagnosis","volume":"8","author":"Moskowitz","year":"2013","journal-title":"Public Libr. Sci."},{"key":"10.1016\/j.ejps.2017.10.033_bb0385","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/625670","article-title":"A comparative systematic review of the optimal CD4 cell count threshold for HIV treatment initiation","volume":"2014","author":"Olubajo","year":"2014","journal-title":"Interdisciplinary Perspectives on Infectious Diseases"},{"key":"10.1016\/j.ejps.2017.10.033_bb0390","first-page":"1","article-title":"Mucocutaneous manifestations of HIV and the correlation with WHO clinical staging in a tertiary hospital in Nigeria","volume":"4","author":"Oninla","year":"2014","journal-title":"AIDS Res. Treat."},{"issue":"2","key":"10.1016\/j.ejps.2017.10.033_bb0395","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jconrel.2011.01.027","article-title":"Advances in oral transmucosal drug delivery","volume":"153","author":"Patel","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2017.10.033_bb0400","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.lwt.2016.10.018","article-title":"Inulin suitable as reduced-kilojoule carrier for production of microencapsulated spray-dried green Cyclopia subternata (honeybush) extract","volume":"75","author":"Pauk","year":"2017","journal-title":"LWT- Food Sci. Technol."},{"issue":"1","key":"10.1016\/j.ejps.2017.10.033_bb0405","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S1461-5347(99)00227-8","article-title":"Application of isothermal microcalorimetry in solid state development","volume":"3","author":"Phipps","year":"2000","journal-title":"Pharm. Sci. Technol. Today"},{"issue":"6","key":"10.1016\/j.ejps.2017.10.033_bb0410","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1080\/20786204.2011.10874147","article-title":"Herpes simplex virus I and II: a therapeutic approach","volume":"53","author":"van der Plas","year":"2011","journal-title":"S. Afr. Fam. Pract."},{"year":"2011","series-title":"The Merck Manual of Diagnosis and Treatment","key":"10.1016\/j.ejps.2017.10.033_bb0415"},{"issue":"2","key":"10.1016\/j.ejps.2017.10.033_bb0420","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1128\/AAC.30.2.215","article-title":"In vitro activity of ketoconazole against herpes simplex virus","volume":"30","author":"Pottage","year":"1986","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.ejps.2017.10.033_bb0425","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1054\/cdip.2000.0025","article-title":"Selected topics in HIV-associated skin pathology","volume":"6","author":"Ramdial","year":"2000","journal-title":"Curr. Diagn. Pathol."},{"key":"10.1016\/j.ejps.2017.10.033_bb0430","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-2559.2009.03456.x","article-title":"Dermatopathological challenges in the human immunodeficiency virus and acquired immunodeficiency syndrome era","volume":"56","author":"Ramdial","year":"2010","journal-title":"Histopathology"},{"year":"2004","series-title":"Drug Delivery Systems","author":"Ranade","key":"10.1016\/j.ejps.2017.10.033_bb0435"},{"key":"10.1016\/j.ejps.2017.10.033_bb0440","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0378-5173(03)00005-X","article-title":"Microcrystals for dissolution rate enhancement of poorly water-soluble drugs","volume":"254","author":"Rasenack","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2017.10.033_bb0445","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.clindermatol.2004.07.007","article-title":"Cutaneous markers of HIV infection","volume":"22","author":"Rigopoulos","year":"2004","journal-title":"Clin. Dermatol."},{"year":"2006","series-title":"Handbook of Pharmaceutical Excipients","key":"10.1016\/j.ejps.2017.10.033_bb0450"},{"key":"10.1016\/j.ejps.2017.10.033_bb0455","series-title":"Basic & Clinical Pharmacology","first-page":"1 230","article-title":"Antiviral agents","author":"Safrin","year":"2015"},{"issue":"1","key":"10.1016\/j.ejps.2017.10.033_bb0460","first-page":"43","article-title":"Intra vaginal drug delivery system: an overview","volume":"1","author":"Sahoo","year":"2013","journal-title":"Am. J. Adv. Drug Deliv."},{"key":"10.1016\/j.ejps.2017.10.033_bb0465","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0040-6031(01)00668-2","article-title":"Rapid, practical and predictive excipient compatibility screening using isothermal microcalorimetry","volume":"380","author":"Schmitt","year":"2001","journal-title":"Thermochim. Acta"},{"author":"Schwartz","key":"10.1016\/j.ejps.2017.10.033_bb0470"},{"key":"10.1016\/j.ejps.2017.10.033_bb0475","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0378-5173(98)00177-X","article-title":"Use of isothermal heat conduction microcalorimetry to evaluate stability and excipient compatibility of a solid drug","volume":"171","author":"Selzer","year":"1998","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2017.10.033_bb0480","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jconrel.2010.11.003","article-title":"Palatal mucosa as a route for systemic drug delivery: a review","volume":"151","author":"Shakya","year":"2011","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.ejps.2017.10.033_bb0485","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0377-1237(04)80054-6","article-title":"Orocutaneous manifestations as markers of disease progression in HIV infection in Indian setting","volume":"60","author":"Sharma","year":"2004","journal-title":"Med. J. Armed Forces India"},{"key":"10.1016\/j.ejps.2017.10.033_bb0490","series-title":"Basic & Clinical Pharmacology","first-page":"1 215","article-title":"Antifingal agents","author":"Sheppard","year":"2015"},{"author":"Sheraz","key":"10.1016\/j.ejps.2017.10.033_bb0495"},{"issue":"2","key":"10.1016\/j.ejps.2017.10.033_bb0500","doi-asserted-by":"crossref","first-page":"86","DOI":"10.4103\/0975-8453.86296","article-title":"Formulation and stability of ascorbic acid in topical preparations","volume":"2","author":"Sheraz","year":"2011","journal-title":"Syst. Rev. Pharm."},{"year":"1988","series-title":"Non Parametric Statistics for the Behaviour Sciences","author":"Siegel","key":"10.1016\/j.ejps.2017.10.033_bb0505"},{"key":"10.1016\/j.ejps.2017.10.033_bb0510","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ijpharm.2011.03.051","article-title":"Higuchi equation: derivation, applications, use and misuse","volume":"418","author":"Siepmann","year":"2011","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ejps.2017.10.033_bb0515","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(99)00279-3","article-title":"Stability assessment of ketoconazole in aqueous formulations","volume":"198","author":"Skiba","year":"2000","journal-title":"Int. J. Pharm."},{"author":"Statsoft, Inc.","key":"10.1016\/j.ejps.2017.10.033_bb0520"},{"year":"1998","series-title":"Moderne Statistiek Vir Die Praktyk. 6de Uitg","author":"Steyn","key":"10.1016\/j.ejps.2017.10.033_bb0525"},{"issue":"2","key":"10.1016\/j.ejps.2017.10.033_bb0530","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.msec.2008.07.030","article-title":"Evaluation of cross-linked chitosan microparticles containing acyclovir obtained by spray-drying","volume":"29","author":"Stulzer","year":"2009","journal-title":"Mater. Sci. Eng. C"},{"year":"2011","series-title":"Martindale: The Complete Drug Reference","author":"Sweetman","key":"10.1016\/j.ejps.2017.10.033_bb0535"},{"issue":"5","key":"10.1016\/j.ejps.2017.10.033_bb0540","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jaad.2007.06.006","article-title":"Adapalene-benzoyl peroxide, a fixed-dose combination for the treatment of acne vulgaris: results of a multicenter, randomized double-blind, controlled study","volume":"57","author":"Thiboutot","year":"2007","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ejps.2017.10.033_bb0545","doi-asserted-by":"crossref","first-page":"1 091","DOI":"10.1016\/S0003-9969(01)00082-6","article-title":"A comparative light-microscopic, electron-microscopic and chemical study of human vaginal and buccal epithelium","volume":"46","author":"Thompson","year":"2001","journal-title":"Arch. Oral Biol."},{"key":"10.1016\/j.ejps.2017.10.033_bb0550","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1365-2133.1997.tb03793.x","article-title":"The prevalence of skin disease in HIV infection and its relationship to the degree of immunosuppression","volume":"137","author":"Uthayakumar","year":"1997","journal-title":"Br. J. Dermatol."},{"issue":"10","key":"10.1016\/j.ejps.2017.10.033_bb0555","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S1461-5347(00)00296-0","article-title":"The scope and potential of vaginal drug delivery","volume":"3","author":"Vermani","year":"2000","journal-title":"Pharm. Sci. Technol. Today"},{"issue":"1","key":"10.1016\/j.ejps.2017.10.033_bb0560","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0377-1237(11)60122-6","article-title":"Cutaneous manifestations of HIV: a detailed study of morphological variants, markers of advanced disease, and the changing spectrum","volume":"68","author":"Vusadevan","year":"2012","journal-title":"Medical Journal of the Armed Forces of India"},{"key":"10.1016\/j.ejps.2017.10.033_bb0565","series-title":"Pharmaceutics: The Design and Manufacture of Medicines","first-page":"675","article-title":"Topical and transdermal drug delivery","author":"Williams","year":"2013"},{"issue":"5","key":"10.1016\/j.ejps.2017.10.033_bb0570","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s10570-007-9137-9","article-title":"Viscosity properties of sodium carboxymethylcellulose solutions","volume":"14","author":"Yang","year":"2007","journal-title":"Cellulose"},{"issue":"1","key":"10.1016\/j.ejps.2017.10.033_bb9005","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s13730-012-0035-0","article-title":"Acute kidney injury due to acyclovir","volume":"2","author":"Yildiz","year":"2013","journal-title":"CEN case Rep."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098717305894?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098717305894?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T04:14:46Z","timestamp":1603253686000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098717305894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":116,"alternative-id":["S0928098717305894"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2017.10.033","relation":{},"ISSN":["0928-0987"],"issn-type":[{"type":"print","value":"0928-0987"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Formulation and evaluation of selected transmucosal dosage forms containing a double fixed-dose of acyclovir and ketoconazole","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2017.10.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}